The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
9 pts

Opinion on  Novartis AG (NVS)     Sector: Healthcare  >  Industry: Major Drugs
My 60 Defensive Growth Stock Picks at Inner8.com

Oct 25, 2008 12:06 AM GMT
Mikerun
Return Risk
+1.04% LOW
Principal

My 60 Defensive Growth Stock Picks at Inner8.com


The accompanying table presents my 60 defensive growth stock picks at the recently launched online investing site Inner8.com , which I wrote about yesterday. My picks are focused on healthcare and consumer staples, along with some cash rich tech companies such as Microsoft (MSFT). My picks include companies across the entire spectrum of market cap and risk in the biotech industry, ranging from top performers such as Amgen (AMGN) and Celgene (CELG) to small and micro-cap picks such as Discovery Labs (DSCO), Cypress Bio (CYPB), and Javelin Pharma (JAV). Other defensive, large-cap picks include JNJ, Procter & Gamble (PG), Philip Morris International (PM), Abbott Labs (ABT), and Wal-Mart (WMT).


NVS:  This call was made on 10/25/08 @ $47.05
Rating:   Positive   $47.05 (10/25/08)
Closed:   11/06/2008 @ $48.77 (+3.66% in 12 days)


Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 21.10 +34.57% 370
2 18.14 +68.57% 207
3 17.66 +25.68% 53
4 13.47 +14.32% 61
5 12.13 +77.15% 34


POPULAR STOCKS
Symbol Company Name Sentiment

TODAY'S HEADLINES

TODAY'S TOP PICKS

 
Novartis AG (NVS)
   SocialPicks Sentiment:   

   This Quarter's Sentiment:
All:
80.5%
Top:
50.0%




Latest Picks by Mike Havrilla
Symbol SP Sentiment Rating Return Since
ACCP Positive n/a 11/11/09
IMUC N/A Positive n/a 11/09/09
EXAS Positive +3.80% 11/07/09
NFES N/A Positive n/a 11/07/09
ESALY N/A Negative n/a 11/04/09

View All >
   
Mike Havrilla previously rated NVS
Positive +22.29% BioMedReports FDA Calendar: Swine Flu Trial Set to Begin
07/21/2009
9
Positive +17.87% Updated FDA, Clinical Trial Calendars: AZN, MYGN, NVS, PSDV
04/08/2009
9
Positive -3.12% A Resurgence in Cell Therapeutics
04/02/2009
9
Positive +4.88% Updated Clinical Trial and FDA Decision Calendars
03/15/2009
9
Positive +3.59% Momenta Pharma's Three-Part Strategy
03/06/2009
9
Positive -28.44% ETFI Global Healthcare Sector PerformIdex
11/14/2008
9
Positive +1.46% Teva Beats on Profits: A Biogeneric Boon in '09?
11/06/2008
9
Positive -4.37% Expanding Defensive Growth Index into Europe
10/23/2008
9
Positive -10.66% A Waiting Game for Momenta Pharma
09/26/2008
3
Positive -6.69% Novartis: An ex-US Proxy for Global Healthcare
07/26/2008
3





IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch